Literature DB >> 365085

Synergistic activity of gentamicin with trimethoprim or sulfamethoxazole-trimethoprim against Escherichia coli and Klebsiella pneumoniae.

J W Paisley, J A Washington.   

Abstract

The effect of combinations of gentamicin with trimethoprim or sulfamethoxazole-trimethoprim against clinical isolates of Escherichia coli (11 strains) and Klebsiella pneumoniae (12 strains) was examined by using a microdilution checkerboard technique. All isolates were susceptible to each antimicrobial agent. Synergism, defined as at least a 2-log(2)-dilution lowering of the minimal inhibitory concentration of either antibiotic in the combination compared with the minimal inhibitory concentration of the antibiotic alone, was observed with 15 of 23 (65%) isolates tested against trimethoprim and gentamicin and 14 of 23 (61%) isolates tested against sulfamethoxazole-trimethoprim and gentamicin. A 3-log(2)-dilution lowering of the minimal inhibitory concentration of either antibiotic was observed in 7 of 23 (30%) trimethoprim and gentamicin trials and 3 of 23 (13%) sulfamethoxazole-trimethoprim and gentamicin trials. Antagonism was observed in 3 of 46 combination trials and only with strains of K. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365085      PMCID: PMC352530          DOI: 10.1128/AAC.14.5.656

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Trimethoprim and rifampicin: in vitro activities separately and in combination.

Authors:  D W Kerry; J M Hamilton-Miller; W Brumfitt
Journal:  J Antimicrob Chemother       Date:  1975-12       Impact factor: 5.790

2.  Clinical significance of in vitro synergism between antibiotics in gram-negative infections.

Authors:  J Klastersky; R Cappel; D Daneau
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

3.  [In vitro bactericidal activity of trimethoprim combined with different antibiotics].

Authors:  R Cluzel; J Sirot; M Cluzel; B Joly
Journal:  Pathol Biol (Paris)       Date:  1972-11

4.  The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens.

Authors:  S Greenfield; D S Feingold
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

5.  Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.

Authors:  J E Rosenblatt; P R Stewart
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

6.  Synergistic activity of trimethoprim and amikacin against gram-negative bacilli.

Authors:  T L Parsley; R B Provonchee; C Glicksman; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

  6 in total
  6 in total

1.  Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.

Authors:  F R Sattler; J S Remington
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

2.  Discrepancies between results obtained by agar and broth techniques in testing of drug combinations.

Authors:  S Kurien; V Lorian
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

3.  A White-Box Machine Learning Approach for Revealing Antibiotic Mechanisms of Action.

Authors:  Jason H Yang; Sarah N Wright; Meagan Hamblin; Douglas McCloskey; Miguel A Alcantar; Lars Schrübbers; Allison J Lopatkin; Sangeeta Satish; Amir Nili; Bernhard O Palsson; Graham C Walker; James J Collins
Journal:  Cell       Date:  2019-05-09       Impact factor: 41.582

4.  Statistical metamodeling for revealing synergistic antimicrobial interactions.

Authors:  Hsiang Chia Chen; Chia Hsiang Chen; Vincent Gau; Donna D Zhang; Joseph C Liao; Fei-Yue Wang; Pak Kin Wong
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

5.  Synergism of trimethoprim combined with aminoglycosides in vitro and in serum of volunteers.

Authors:  S H Zinner; H Lagast; A Kasry; J Klastersky
Journal:  Eur J Clin Microbiol       Date:  1982-06       Impact factor: 3.267

Review 6.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.